Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CH-31
- Development stage
- Unknown
- Lead developer
- Curanter
- Administration
- Oral
01
Overview
CH-31 is a homeopathic remedy developed and marketed by Curanter Homeo, a homeopathic product retailer based in Patna, India. The product is available in oral forms, including drops and tablets. As a homeopathic preparation, CH-31 is sold as a finished retail product rather than a therapeutic candidate undergoing conventional pharmaceutical research and development. There is no clinical data or specific pharmacological mechanism of action provided for the product, and its specific indications are not publicly detailed on the developer's e-commerce platform. It is part of a commercial product line ranging from CH-19 to CH-31.
- Brand names
- CH-31CH31CH 31
- Other names
- CH-31 dropsCH31 dropsCH 31 dropsCH-31 tabletsCH31 tabletsCH 31 tablets
Beyond the preview
Go deeper on CH-31.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CH-31.